中文 | ENG

第57卷 第2期 2024-3
Necrotizing fasciitis resulted from foreign body ingestion and intestinal perforation in an incisional hernia: Report of a case

.........................

第57卷 第2期 2024-3
Application of artificial intelligence in endodontic microsurgery

.........................

第57卷 第2期 2024-3
A rare case of cerebral metastasis of malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1

.........................

第57卷 第2期 2024-3
Ethic in commenting and clinical surgery journal publication: Emerging issue in the era of social media—A story from “Beall” to “Jaime” and independent researcher

.........................

第57卷 第2期 2024-3
Ophidascaris robertsi, the new emerging human parasite and neurosurgery

.........................

第57卷 第2期 2024-3
Tetanus toxoid IgG, usefulness in clinical surgery, and diagnostic property limitation

.........................

第57卷 第2期 2024-3
Deaths among surgeons while on duty: An important issue in surgery and occupational medicine that should not be disregarded

.........................

第57卷 第2期 2024-3
ChatGPT and its use in clinical surgery: A comment on its pro and con

.........................

第57卷 第2期 2024-3
Isolated spinal neurocysticercosis and pseudotumor cerebri: Tropical problem to be noted

.........................

第57卷 第2期 2024-3
Management of massive hemothorax resulting from traumatic diaphragm rupture with kidney avulsion injury by combined anterior thoracoabdominal approaches

.........................

第57卷 第2期 2024-3
Laparoscopic partial splenectomy for sclerosing angiomatoid nodular transformation: A case report and literature review

.........................

第57卷 第2期 2024-3
Using three-dimensional versus two-dimensional laparoscopy in sleeve gastrectomy: A case matched comparison

.........................

第57卷 第2期 2024-3
Effectiveness of placing prophylactic mesh with the Sugarbaker technique via laparoscopic abdominoperineal resection for rectal cancer: 1-year results

.........................

第57卷 第2期 2024-3
Nylon cable ties–assisted delay primary closure of fasciotomy wound in patients of forearm compartment syndrome

.........................

第57卷 第2期 2024-3
Prefabricated venous fl ap, an advanced free venous fl ap for distant transfer: An experimental rat study

.........................

第57卷 第1期 2024-1
Isolated lower leg monoplegia due to traumatic intraparenchymal hemorrhage

.........................

第57卷 第1期 2024-1
Reflections on the association between cholecystectomy, cholelithiasis, and colorectal cancer

.........................

第57卷 第1期 2024-1
Molluscum contagiosum, false positive, and incidence: Concern in surgery

.........................

第57卷 第1期 2024-1
New form of COVID-19 vaccine: A new advanced technology for fighting the remained problem

.........................

第57卷 第1期 2024-1
COVID-19 vaccination, acute appendicitis, interrelationship, and jointed probability: A concern

.........................
登入帳號才能閱讀全文
 
篇名 Nadir prostate‑specific antigen as a prognostic factor of 10‑year cancer‑specific survival of prostate cancer patients with bone metastases
作者 Chi‑Feng Hung, Tsung‑Wei Wang, Cheng‑Kuang Yang, Yung‑Cheng Yang, Yeong‑Chin Jou, Yen‑Chuan Ou
卷期/出版年月 55卷5期 (2022/9)
頁次 184-189
摘要 Background: In Taiwan, the proportion of men with newly diagnosed bony metastatic prostate cancer (PC) is approximately 30%. The present study aims to determine the 10‑year cancer‑specific survival rate and clinical prognostic factors of men with newly diagnosed bone metastatic PC that were treated with hormone therapy. Materials and Methods: Between January 1983 and December 2008, 257 patients with bone metastatic PC were identified at initial diagnosis. Clinical and pathological data were collected from their medical chart records. Performance status, body mass index, clinical symptoms, initial serum prostate‑specific antigen (PSA), nadir PSA level (nPSA), and treatment modality were reviewed retrospectively. Statistical methods included descriptive statistics, bivariate analyses, Kaplan–Meier survival analyses, and Cox regression analysis for investigating the relationship between the clinical factors and disease survival. Results: The average follow‑up time was 36.4 months (±29.1 months) and the median survival time was 58.1 months. Using Kaplan–Meier survival analyses, the overall 10‑year survival rate was 33%. The multivariate Cox regression hazard model revealed that patients with a posttreatment nPSA level >10 ng/mL have a higher probability of death than those with an nPSA <0.5 ng/mL (Hazard ration: 2.63, 95% confidence interval: 1.16–5.97, P = 0.020). Conclusion: Posttreatment nadir serum PSA level significantly influences the survival of patients with bone metastatic PC. A lower limit of 0.5 ng/mL for the nPSA level is a valuable prognostic factor for survival in patients initially diagnosed with bone metastatic PC and treated with hormone therapy.
關鍵詞 Metastasis, prognosis, prostate neoplasms, prostate‑specific antigen
分類 Original Articles

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@24drs.com